{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T08:21:52Z","timestamp":1774167712510,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,5,1]],"date-time":"1995-05-01T00:00:00Z","timestamp":799286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1995,5]]},"DOI":"10.1007\/bf01521338","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T19:25:02Z","timestamp":1113852302000},"page":"137-145","source":"Crossref","is-referenced-by-count":7,"title":["The relationship between flow-cytometric and immunohistochemically detected c-erbB-2 expression, grade and DNA ploidy in breast cancer"],"prefix":"10.1007","volume":"41","author":[{"given":"Ian","family":"Brotherick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian K.","family":"Shenton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William K.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Angus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H. W.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W. J.","family":"Lennard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1126\/science.3289120","volume":"240","author":"IU Ali","year":"1988","unstructured":"Ali IU, Campbell G, Lidereau R, Callahan R (1988) Amplification of c-erb B-2 and aggressive human breast tumours? Science 240:1795","journal-title":"Science"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/path.1711530411","volume":"153","author":"B Angus","year":"1987","unstructured":"Angus B, Purvis J, Stock D, Westley BR, Samson ACR, Routledge EG, Carpenter FH, Horne CHW (1987) A new monoclonal antibody recognising low molecular weight cytokeratins effective for immunohistochemistry using formalin-fixed paraffin embedded tissue. J Pathol 153:377","journal-title":"J Pathol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/bmj.299.6707.1061","volume":"299","author":"DM Barnes","year":"1988","unstructured":"Barnes DM (1988) Editorial. Breast cancer and a protooncogene. Br Med J 299:1061","journal-title":"Br Med J"},{"key":"CR4","first-page":"1238","volume":"48","author":"MS Berger","year":"1988","unstructured":"Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE (1988) Correlation of the c-erb B-2 gene amplifications and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48:1238","journal-title":"Cancer Res"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/cyto.990160311","volume":"16","author":"I Brotherick","year":"1994","unstructured":"Brotherick I, Lennard TWJ, Wilkinson SE, Cook S, Angus B, Shenton BK (1994) A flow cytometric method for the measurement of epidermal growth factor receptor and a comparison with the radio-ligand binding assay. Cytometry 16:262","journal-title":"Cytometry"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/bmj.309.6963.1222","volume":"309","author":"NJ Bundred","year":"1994","unstructured":"Bundred NJ, Morgan DAL, Dixon JM (1994) Management of regional nodes in breast cancer. Br Med J 309:1222","journal-title":"Br Med J"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1200\/JCO.1987.5.7.999","volume":"5","author":"MJ Cline","year":"1987","unstructured":"Cline MJ, Battifora H, Yokota J (1987) Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease. J Clin Oncol 5:999","journal-title":"J Clin Oncol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/path.1711610105","volume":"161","author":"IP Corbett","year":"1990","unstructured":"Corbett IP, Henry JA, Angus B, Watchorn CJ, Wilkinson L, Hennessey C, Gullick WJ, Tuzi NL, May FEB, Westley BR, Horne CHW (1990) NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erb B-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue. J Pathol 161:15","journal-title":"J Pathol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/cyto.990080217","volume":"8","author":"CJ Cornelisse","year":"1987","unstructured":"Cornelisse CJ, Van de Velde CJH, Caspers RJC, Moolenaar AJ, Hermans J (1987) DNA ploidy and survival in breast cancer patients. Cytometry 8:225","journal-title":"Cytometry"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.2999974","volume":"230","author":"L Coussens","year":"1985","unstructured":"Coussens L, Yang-Feng, TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson A, Ullrich A (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1130","journal-title":"Science"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000163617","volume":"59","author":"DC Dawson","year":"1991","unstructured":"Dawson DC, Scheppler JA, Nicholson JKA, Holman RC (1991) Enumeration of antigen sites of cells by flow cytometry. Pathobiology 59:57","journal-title":"Pathobiology"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/path.1711630205","volume":"163","author":"R Dykins","year":"1991","unstructured":"Dykins R, Corbett IP, Henry JA, Wright C, Yuan J, Hennessey C, Lennard TWJ, Angus B, Horne CHW (1991) Long-term survival in brast cancer related to overexpression of the c-erbB-2 oncoprotein: an immunohistochemical study using monoclonal antibody NCL-CB11. J Pathol 163:105","journal-title":"J Pathol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ijc.2910410608","volume":"41","author":"GE Feichter","year":"1988","unstructured":"Feichter GE, Mueller A, Kaufmann M, Haag D, Born IA, Abel U, Klinga K, Kubli F, Goetler K (1988) Correlation of DNA cytometric results and other prognostic factors in primary breast cancer. Int J Cancer 41:823","journal-title":"Int J Cancer"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/cyto.990110609","volume":"11","author":"M Ferrero","year":"1990","unstructured":"Ferrero M, Spyratos F, Le Dousall V, Desplaces A, Rou\u00ebss\u00e9 J (1990) Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in malignant tumors. Cytometry 11:716","journal-title":"Cytometry"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3","volume":"52","author":"B Fisher","year":"1983","unstructured":"Fisher B (1983) Relation of number of positive axillary nodes to prognosis of patients with primary breast cancer. Cancer 52:1551","journal-title":"Cancer"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/1097-0142(19911001)68:7<1465::AID-CNCR2820680702>3.0.CO;2-I","volume":"68","author":"B Fisher","year":"1991","unstructured":"Fisher B, Gunduz N, Costantino J, Fisher ER, Redmond C, Mamounas EP, Siderits R (1991) DNA flow cytometric analysis of primary operable breast cancer. Cancer 68:1465","journal-title":"Cancer"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjc.1991.100","volume":"63","author":"WJ Gullick","year":"1991","unstructured":"Gullick WJ, Love SB, Wright C, Barnes DM, Gusterson B, Harris A (1991) c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer 63:434","journal-title":"Br J Cancer"},{"key":"CR18","first-page":"5395","volume":"44","author":"DW Hedley","year":"1984","unstructured":"Hedley DW, Rugg CA, Ng APB, Taylor IW (1984) Influence of cellular DNA content on disease-free survival of stage II breast cancer patients. Cancer Res 44:5395","journal-title":"Cancer Res"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/cyto.990140505","volume":"14","author":"DW Hedley","year":"1993","unstructured":"Hedley DW, Clark GM, Cornelisse CJ, Killander D, Kute T, Merkel D (1993) Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry 14:482","journal-title":"Cytometry"},{"key":"CR20","first-page":"469","volume-title":"Clinical flow cytometry: principles and application","author":"RA Hoffman","year":"1993","unstructured":"Hoffman RA, Recktenwald DJ, Vogt J (1993) Cell-associated receptor quantitation. In: Clinical flow cytometry: principles and application. Bauer KD, Duque RE, Shankey TV (eds) Williams & Wilkins, Baltimore, p 469"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2559.1990.tb00714.x","volume":"17","author":"L Keatings","year":"1990","unstructured":"Keatings L, Sinclair J, Wright C, Corbett IP, Watchorn C, Hennessy C, Angus B, Lennard TWJ, Horne CHW (1990) c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study. Histopathology 17:243","journal-title":"Histopathology"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/cyto.990110411","volume":"11","author":"ML Kelsten","year":"1990","unstructured":"Kelsten ML, Berger MS, Maguire HC, Chianese DA, Hellman ME, Weiner DB, Greene MI (1990) Analysis of c-erbB-2 protein expression in conjunction with DNA content using multiparameter flow cytometry. Cytometry 11:522","journal-title":"Cytometry"},{"key":"CR23","first-page":"2053","volume":"33","author":"JG Lopez","year":"1992","unstructured":"Lopez JG, Chew SJ, Thompson HW, Malter JS, Insler MS, Beuerman RW (1992) Surface receptor quantitation on ocular cells by an immunocytochemical flow cytometry technique. Investigative Opthalmol 33:2053","journal-title":"Investigative Opthalmol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/bjc.1991.101","volume":"63","author":"C Lovekin","year":"1991","unstructured":"Lovekin C, Ellis IO, Locker A, Robertson FR, Bell J, Nicholson R, Gullick WJ, Elston CW, Blamey RW (1991) c-erbB-2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer 63:439","journal-title":"Br J Cancer"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.1990.8.1.103","volume":"8","author":"S Paik","year":"1990","unstructured":"Paik S, Hazan R, Fisher ER, Sass RE, Fisher B, Redmond C, Schlessinger J, Lippmann ME, King CR (1990) pathological findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance oferbB-2 protein overexpression in primary breast cancer. J Clin Oncol 8:103","journal-title":"J Clin Oncol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/bjc.1991.78","volume":"63","author":"TJ Perren","year":"1991","unstructured":"Perren TJ (1991) c-erbB-2 oncogene as a prognostic marker in breast cancer. Br J Cancer 63:328","journal-title":"Br J Cancer"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0022-1759(89)90221-4","volume":"123","author":"KM Rigg","year":"1989","unstructured":"Rigg KM, Shenton BK, Murray IA, Givan AL, Taylor RMR, Lennard TWJ (1989) A flow cytometric technique for simultaneous analysis of human mononuclear cell-surface antigens and DNA. J Immunol Methods 123:177","journal-title":"J Immunol Methods"},{"key":"CR28","first-page":"6941","volume":"49","author":"J Ro","year":"1989","unstructured":"Ro J, El-Nagger A, Ro JY, Blick M, Frye D, Fraschini G, Fritche H, Hortobagyi G (1989) c-erbB-2 amplification in node negative human breast cancer. Cancer Res 49:6941","journal-title":"Cancer Res"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/ajcp\/64.6.756","volume":"64","author":"SG Silverberg","year":"1975","unstructured":"Silverberg SG (1975) Staging in the therapy of cancer of the breast. Am J Clin Pathol 64:756","journal-title":"Am J Clin Pathol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of HER\/2neu oncogene. Science 235:177","journal-title":"Science"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","volume":"244","author":"DJ Slamon","year":"1989","unstructured":"Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989) Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer. Science 244:707","journal-title":"Science"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/bjc.1989.303","volume":"60","author":"M Tavassoli","year":"1989","unstructured":"Tavassoli M, Quirke P, Farzaneh F, Lock NJ, Mayne LV, Kirkham N (1989) c-erbB-2\/cerbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma. Br J Cancer 60:505","journal-title":"Br J Cancer"},{"key":"CR33","first-page":"3104","volume":"49","author":"H Tsuda","year":"1989","unstructured":"Tsuda H, Hirohashi S (1989) Correlation between long-term survival in breast cancer patients and amplification of two putatative oncogene-coamplification units:hst-1\/int-2 and c-erbB-2\/ear-1. Cancer Res 49:3104","journal-title":"Cancer Res"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/cyto.990100110","volume":"10","author":"JC Linden Van der","year":"1989","unstructured":"Van der Linden JC, Lindeman J, Baak JPA, Meijer CJLM, Herman CJ (1989) The multivariate prognostic index and nuclear DNA content are independent prognostic factors in primary breast cancer patients. Cytometry 10:56","journal-title":"Cytometry"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(87)92736-X","volume":"II","author":"DJ Ventner","year":"1987","unstructured":"Ventner DJ, Tuzi NL, Kumar S, Gullick WJ (1987) Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet II:69","journal-title":"Lancet"},{"key":"CR36","first-page":"171","volume":"25","author":"DV Visscher","year":"1990","unstructured":"Visscher DV, Zarbo RJ, Green A, Crissman JD (1990) Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast. Pathol Ann 25:171","journal-title":"Pathol Ann"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/bjc.1991.112","volume":"63","author":"J Winstanley","year":"1991","unstructured":"Winstanley J, Cooke T, Murray GD, Platt-Higgins A, George WD, Holt S, Myskov M, Spedding A, Barraclough BR, Rudland PS (1991) The long term prognostic significance of c-erbB-2 in primary breast cancer. Br J Cancer 63:477","journal-title":"Br J Cancer"},{"key":"CR38","first-page":"2087","volume":"49","author":"C Wright","year":"1989","unstructured":"Wright C, Angus B, Nicholson S, Sainsbury JRC, Cairns J, Gullick WJ, Kelly P, Harris AC, Horne CHW (1989) Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res 49:2087","journal-title":"Cancer Res"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/bjc.1990.375","volume":"62","author":"C Wright","year":"1990","unstructured":"Wright C, Mellon K, Neal DE, Corbett IP, Horne CHW (1990) Expression of c-erbB-2 protein in bladder cancer. Br J Cancer 62:764","journal-title":"Br J Cancer"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/319230a0","volume":"319","author":"T Yamamoto","year":"1986","unstructured":"Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K (1986) Similarity of the protein encoded by human c-erbB-2 gene to epidermal growth factor receptor. Nature 319:230","journal-title":"Nature"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.bi.50.070181.003301","volume":"50","author":"DE Yelton","year":"1981","unstructured":"Yelton DE, Scharf MD (1981) Monoclonal antibodies: a powerful new tool in biology and medicine. Annu Rev Biochem 50:657","journal-title":"Annu Rev Biochem"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/bjs.1800780724","volume":"78","author":"J Yuan","year":"1991","unstructured":"Yuan J, Hennessey C, Corbett IP, Dykin R, Givan AL, Shenton BK, Henry JA, Wright C, Lennard TWJ (1991) Node negative breast cancer: the prognostic value of DNA ploidy for long-term survival. Br J Surg 78:844","journal-title":"Br J Surg"},{"key":"CR43","first-page":"6123","volume":"47","author":"D Zhou","year":"1987","unstructured":"Zhou D, Battifora H, Yokata J, Yamamoto T, Cline MJ (1987) Association of muliple copies of the c-erbB-2 oncogene with spread of breast disease. Cancer Res 47:6123","journal-title":"Cancer Res"}],"container-title":["Cancer Immunology Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01521338\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01521338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01521338\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01521338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T09:02:41Z","timestamp":1556874161000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01521338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,5]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,5]]}},"alternative-id":["BF01521338"],"URL":"https:\/\/doi.org\/10.1007\/bf01521338","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,5]]}}}